CSG's Polish Trade-Show Push Coincides With a Share Price Caught in the Doldrums

CSG presents at MSPO amid 52% stock drop; H1 revenue up 17.2%, but negative cash flow from inventory build spooks investors.

The Czech defence group CSG will field eight of its subsidiaries at the MSPO arms fair in Kielce next week, a display of heft that lands at an awkward moment for the company's stock. Tatra Export, Excalibur Army, Tatra Defence, MSM Group, Vývoj Martin, AviaNera Technologies, CSG Polska and Polish partner Domar MS will occupy Hall 4 and two outdoor areas from 8-11 September.

The trade-show presence underscores how seriously CSG courts the Polish market, one of central Europe's most important defence procurement arenas. Yet the optics of a confident, public-facing sales push sit uneasily against a share price that has been sliding for weeks.

A Tale of Two Trajectories

The equity closed at €17.27, down 9.7% over the past week and 7.0% lower on a monthly basis. That leaves the stock roughly 52% below its January 52-week high of €36.05. The relative strength index reads 44.7 — technically neutral territory, offering little directional signal to chart-watchers.

The disconnect between operational vigour and market performance is striking. First-half 2026 results, published in early August, showed revenue of €3.251 billion, a 17.2% improvement year-on-year. Operating EBIT advanced 12.7% to €784 million, with margins holding at 24.1%, in line with guidance. Net profit from continuing operations jumped 84.8% to €572 million, propelled by a 27% revenue surge in the Defence Systems division as NATO governments restock ammunition inventories.

So why the persistent share-price weakness? The answer lies not in the income statement but on the balance sheet.

Inventory Build Ties Up Cash

CSG posted a negative operating cash flow before taxes of €411 million, a figure the company attributes to a deliberate build-up of component inventories, particularly in the medium- and large-calibre ammunition segment. Management insists the effect will unwind in the second half, with the fourth quarter flagged as the period when working capital should normalise.

The company has reaffirmed its full-year target of keeping net working capital below 20% of revenue. But the prospect of waiting several months for that cash release is clearly giving investors pause, even as the underlying earnings picture remains robust.

The market's caution is understandable. A defence contractor that is growing quickly while consuming cash requires patience — a commodity not always in abundant supply among equity investors. The annualised volatility of 55% suggests the stock remains prone to sharp swings in either direction.

Order Book Provides the Counterweight

Against the short-term drag of capital tied up in inventory stands a swelling order book. Total backlog, including contracts under negotiation, has grown from €44 billion in March to €46 billion. Notably, Land Systems now contributes the largest single share — evidence that CSG is broadening beyond its ammunition manufacturing core, a shift that should widen the group's earnings base over time.

Recent contract wins reinforce the momentum narrative. Federal Ammunition, part of CSG's Kinetic Group, has been selected by Nordic police forces to supply service and training ammunition. Earlier in the year, CSG signed contracts for large-calibre rounds worth nearly €300 million and 155mm artillery ammunition valued at around €250 million for a European customer.

August brought an additional strategic investment: the acquisition of the Gnaschwitz industrial site in Saxony from MAXAM, with more than €100 million earmarked for nitro-glycerine and munitions component production.

Leadership and Technical Position

The management suite has also seen recent change. Ben Hudson, a defence industry veteran with over three decades of experience, joined the board as vice-chairman roughly a month ago. The stock gained 3.8% in the immediate aftermath of that announcement before the latest soft patch set in.

Technically, the shares are trading just above their 50-day moving average of €16.42, while still sitting 41% above the 52-week low of €12.20. That wide range between high and low captures the stock's turbulent journey over the past year.

CSG maintains its full-year revenue guidance of €7.4-7.6 billion, first communicated at the time of its initial public offering. The next earnings report is scheduled for 11 November, by which point the market will be watching intently whether the promised inventory unwind materialises into a genuine cash-flow recovery. Until then, the central question for investors remains whether this share-price softness is merely a pause for breath or something more enduring — a question only the fourth-quarter numbers can definitively answer.